Dtsch Med Wochenschr 2017; 142(18): 1357-1364
DOI: 10.1055/s-0042-117249
Dossier
© Georg Thieme Verlag KG Stuttgart · New York

Organinteraktionen: Herz und Lunge – Management des akuten Rechtsherzversagens

Organ Interactions: Heart and Lung – Management of the Acute Right Heart Failure
Guido Michels
,
Roman Pfister
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
08. September 2017 (online)

Abstract

The pathophysiology and the management of patients with acute right heart failure are very complex. The bed-side focused echocardiography is the basis of differential diagnosis and acute diagnosis. Individual therapy monitoring is complex due to the strong preload dependence of the right ventricle and the limitation of non-invasive estimation of pulmonary-vascular hemodynamics, so that the indication for a pulmonary artery catheter should be liberal in acute right heart failure. The treatment goals of acute right heart failure are the treatment of the underlying disease or triggering factors in combination with individualized optimization of hemodynamic tailored to current right-ventricular function.

Die Pathophysiologie, das Management und die individuelle Therapiesteuerung von Patienten mit akutem Rechtsherzversagen (RVF) sind komplex. Basis der Differenzial- und Akutdiagnostik ist die bettseitige fokussierte Echokardiografie. Behandlungsziele sind die Behandlung der Grunderkrankung bzw. der auslösenden Faktoren in Kombination mit einer individuell an die vorliegende rechtsventrikuläre Funktion angepasste Optimierung der Hämodynamik.

 
  • Literatur

  • 1 Feihl F, Broccard AF. Interactions between respiration and systemic hemodynamics Part I: basic concepts. Intensive Care Med 2009; 35 (01) 45-54
  • 2 Feihl F, Broccard AF. Interactions between respiration and systemic hemodynamics. Part II: practical implications in critical care. Intensive Care Med 2009; 35 (02) 198-205
  • 3 Harjola VP, Mebazaa A, Čelutkienė J. et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 2016; 18 (03) 226-241
  • 4 Galiè N, Humbert M, Vachiery JL. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37 (01) 67-119
  • 5 Ponikowski P, Voors AA, Anker SD. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37 (27) 2129-2200
  • 6 Olsson KM, Halank M, Egenlauf B. et al. Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension. Dtsch Med Wochenschr 2016; 141 (Suppl. 01) S42-S47
  • 7 Hempel D, Pfister R, Michels G. Hemodynamic monitoring in intensive care and emergency medicine: Integration of clinical signs and ultrasound findings. Med Klin Intensivmed Notfmed 2016; 111 (07) 596-604
  • 8 Lang RM, Badano LP, Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16 (03) 233-270
  • 9 Cecconi M, DeBacker D, Antonelli M. et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care 2014; 40 (12) 1795-1815
  • 10 Janssens U, Jung C, Hennersdorf H. et al. Empfehlungen zum hämodynamischen Monitoring in der internistischen Intensivmedizin. Kardiologe 2016; 10: 149-169
  • 11 Michels G, Kochanek M. Repetitorium Internistische Intensivmedizin. Heidelberg: Springer; 2017 3. Aufl.
  • 12 Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med 2011; 184 (10) 1114-1124
  • 13 Kerbaul F, Rondelet B, Demester JP. et al. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2006; 34: 2814-2819
  • 14 Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology 1984; 60: 132-135
  • 15 Coz Yataco A, Aguinaga Meza M, Buch KP. et al. Hospital and intensive care unit management of decompensated pulmonary hypertension and right ventricular failure. Heart Fail Rev 2016; 21 (03) 323-346
  • 16 Kramm T, Guth S, Wiedenroth CB. et al. Treatment of acute and chronic right ventricular failure. Med Klin Intensivmed Notfmed 2016; 111 (05) 463-480
  • 17 Rossaint R, Falke KJ, Lopez F. et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328 (06) 399-405
  • 18 Gebistorf F, Karam O, Wetterslev J. et al. The effect of inhaled nitric oxide in acute respiratory distress syndrome in children and adults: a Cochrane Systematic Review with trial sequential analysis. Anaesthesia 2017; 72 (01) 106-117
  • 19 Christenson J, Lavoie A, O’connor M. et al. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt with drawl of inhaled nitric oxide. Am J Respir Crit Care Med 2000; 161: 1443-1449
  • 20 Lepore JJ, Maroo A, Pereira NL. et al. Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. Am J Cardiol 2002; 90: 677-680
  • 21 Rosenzweig EB, Brodie D, Abrams DC. et al. Extracorporeal membrane oxygenation as a novel bridging strategy for acute right heart failure in group 1 pulmonary arterial hypertension. ASAIO J 2014; 60: 129-133